A meningomyelocele with normal intracranial signs on ultrasound and false-negative amniotic fluid alpha-fetoprotein and acetylcholinesterase
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Neural tube defects are the major targets of prenatal diagnoses, along with Down syndrome. Prenatal diagnosis of spina bifida is possible at second trimester of gestation through α-fetoprotein and acetylcholinesterase biochemistry assays and ultrasound. In particular, the discovery of characteristic intracranial signs on ultrasound leads to a very high diagnosis rate. However, it is rare for spina bifida to present without intracranial signs while also showing normal values of maternal serum α-fetoprotein, amniotic fluid α-fetoprotein, and acetylcholinesterase. In our hospital, a fetus with spina bifida was delivered at 37+5 weeks’ gestation by cesarean section, and was continually followed up over 2 years to date.
Abstract
Neural tube defects are the major targets of prenatal diagnoses, along with Down syndrome. Prenatal diagnosis of spina bifida is possible at second trimester of gestation through α-fetoprotein and acetylcholinesterase biochemistry assays and ultrasound. In particular, the discovery of characteristic intracranial signs on ultrasound leads to a very high diagnosis rate. However, it is rare for spina bifida to present without intracranial signs while also showing normal values of maternal serum α-fetoprotein, amniotic fluid α-fetoprotein, and acetylcholinesterase. In our hospital, a fetus with spina bifida was delivered at 37+5 weeks’ gestation by cesarean section, and was continually followed up over 2 years to date.
참고문헌 (14)
- Nicolaides KH, "Ultrasound screening for spina bifida: cranial and cerebellar signs", Lancet, 2, pp.72~74 (1986)
- Pierre-Kahn A, "Lumbosacral lipomas: in utero diagnosis and prognosis", Childs Nerv Syst, 19, pp.551~554 (2003)
- Nievelstein RA, "Embryonic development of the mammalian caudal neural tube", Teratology, 48, pp.21~31 (1993)
- Boulet SL, "Trends in the postfortification prevalence of spina bifida and anencephaly in the United States", Birth Defects Res A Clin Mol Teratol, 82, pp.527~532 (2008)
- Kondo A, "Neural tube defects:prevalence, etiology and prevention", Int J Urol, 16, pp.49~57 (2009)
- Sebire NJ, "Maternal serum alpha-fetoprotein in fetal neural tube and abdominal wall defects at 10 to 14 weeks of gestation", Br J Obstet Gynaecol, 104, pp.849~851 (1997)
- Loft AG, "A comparison of amniotic fluid alpha-fetoprotein and acetylcholinesterase in the prenatal diagnosis of open neural tube defects and anterior abdominal wall defects", Prenat Diagn, 13, pp.93~109 (1993)
- Boogert A, "Falsenegative amniotic fluid acetylcholinesterase in a case of meningo-encephalocele", Prenat Diagn, 9, pp.133~138 (1989)
- Harmon JP, "Prenatal ultrasound detection of isolated neural tube defects:is cytogenetic evaluation warranted?", Obstet Gynecol, 86(4 Pt 1), pp.595~599 (1995)
- Watson WJ, "The role of ultrasound in evaluation of patients with elevated maternal serum alpha-fetoprotein: a review", Obstet Gynecol, 78, pp.123~128 (1991)
- Tabor A, "Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study", Ultrasound Obstet Gynecol, 34, pp.19~24 (2009)
- Cheschier N, "ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin: Neural tube defects. Number 44, July 2003 (Replaces committee opinion number 252, March 2001)", Int J Gynaecol Obstet, 83, pp.123~133 (2003)
- Bell JE, "The association of hydrocephalus and Arnold: Chiari malformation with spina bifida in the fetus", Neuropathol Appl Neurobiol, 6, pp.29~39 (1980)
- Anteby EY, "Route of delivery of fetuses with structural anomalies", Eur J Obstet Gynecol Reprod Biol, 106, pp.5~9 (2003)